Frederiksstaden Pharma ApS: Financial statements 2018
CVR: 25630483
Source: annual report 2018, Danish Business Authority
01/05/2017 – 30/04/2018
Frederiksstaden Pharma ApS (CVR 25630483) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 2,163,299 and a net result of DKK -6,239,627 compared with DKK -2,380,145 the year before. That is a decrease of 61.6% compared with the year before. Equity in the 2018 report amounted to DKK 1,058,335. The solvency ratio was 45.7%.
- Gross Profit
- DKK 2,163,299
- Profit/Loss
- DKK -6,239,627
- Equity
- DKK 1,058,335
- Total Assets
- DKK 2,316,502
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | 2.2 mio. | -6.2 mio. | 1.1 mio. | - |
| 2017 | - | 5.6 mio. | -2.4 mio. | 7.3 mio. | - |
| 2014 | - | 3.5 mio. | -286 t. | -2.2 mio. | 14 |
| 2013 | - | 3.8 mio. | -2.3 mio. | -1.9 mio. | 14 |
| 2012 | - | 6.7 mio. | 40 t. | 426 t. | 19 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
As of September 20, 2018, Lars Grundtvig has joined the board of directors of Frederiksstaden Pharma ApS.
As of September 20, 2018, Lars Karlsmose has joined the board of directors of Frederiksstaden Pharma ApS.
As of September 19, 2018, Lars Grundtvig has left the board of directors of Frederiksstaden Pharma ApS.
About Frederiksstaden Pharma ApS
Frederiksstaden Pharma ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2000. The company is registered under the industry Pakkeriaktiviteter. The company was previously named NPPHorsholm ApS and Nord Pharma Partners ApS. The management consists of Jens-Nikolaj Schøier. The company is owned by XGX Pharma ApS. The company has 2 employees (2021). In 2025, the company reported a gross profit of DKK 61,605 and a net result of DKK 139,819 compared with DKK -50,518 the year before. Equity in the 2025 report amounted to DKK 237,986.